knowledge -WSS

knowledge

author：leisure time 2025-10-01 07:40:39 - browse：1185

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Will General Catalyst be the first of many hospital takeovers?

hotspot

WSS

Victims of gun violence feel impacts long after bullet wound

Public health communication lessons from Covid

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Hospitals, health systems can help patients avoid medical debt

VC firm RA Capital starts a new synthetic biology incubator

Timeline: Special counsel's probe into Trump's handling of classified documents

focus

knowledge

hotspot

In age of alternative facts, a scholarly course on calling out crap

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Continuity nursing helped my family in our darkest PICU moments

The mammogram wars are not over

Duchenne breakthrough therapy leaves behind pioneering families

HPV cancer vaccine study demonstrates efficacy

ChatGPT in medicine: STAT answers readers' burning questions

Victims of gun violence feel impacts long after bullet wound

Psychedelics group wrestles with new pharma identity

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

hotspot

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Stoke drug shows lower activity against childhood epilepsy

Ambulance rides for just $100? Advisers want major billing fixes

HPV cancer vaccine study demonstrates efficacy

HPV cancer vaccine study demonstrates efficacy

Public health communication lessons from Covid

hotspot

explore

leisure time

hotspot